Evidence map›Paper›PMID 39539388›Full record

ArticleBiology methods & protocols2024

Implementation of plate reader-based indooxine and Nessler protocols for monitoring L-asparaginase serum activity in childhood acute lymphoblastic leukaemia.

Bozhidar Vergov, Yordan Sbirkov, Danail Minchev, Tatyana Todorova, Alexandra Baldzhieva, Hasan Burnusuzov, Мariya I Spasova, Victoria Sarafian

Abstract read
In one paragraph

Article in Biology methods & protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bozhidar VergovDepartment of Medical Biology, Medical University of Plovdiv, Plovdiv 4000, Bulgaria.ORCID https://orcid.org/0000-0002-9275-703X
Yordan SbirkovDepartment of Medical Biology, Medical University of Plovdiv, Plovdiv 4000, Bulgaria.ORCID https://orcid.org/0000-0002-6554-3773
Danail MinchevDepartment of Human Anatomy and Physiology, University of Plovdiv 'Paisii Hilendarski', 24 Tzar Asen St, Plovdiv 4000, Bulgaria.
Tatyana TodorovaDepartment of Medical Biology, Medical University of Plovdiv, Plovdiv 4000, Bulgaria.
Alexandra BaldzhievaResearch Institute at Medical University of Plovdiv, Plovdiv 4000, Bulgaria.
Hasan BurnusuzovResearch Institute at Medical University of Plovdiv, Plovdiv 4000, Bulgaria.
Мariya I SpasovaDepartment of Pediatrics, Medical University of Plovdiv, Plovdiv 4000, Bulgaria.
Victoria SarafianDepartment of Medical Biology, Medical University of Plovdiv, Plovdiv 4000, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring the blood serum activity of L-asparaginase in children with acute lymphoblastic leukaemia (ALL) has been highly recommended to detect enzyme inactivation that can cause relapse and to avoid unwanted toxicity. Nevertheless, perhaps at least partially due to the lack of clinically approved commercially available kits or standardized and independently reproduced and validated in-house protocols, laboratory assay-based determination of the optimal doses of L-asparaginase is not carried out routinely. In this study, we adapted previously published protocols for two plate reader-based colorimetric methods, indooxine and Nessler, to measure asparaginase activity. Mock samples with dilutions of the enzyme for initial optimization steps, and patient samples were used as a proof of principle and to compare the two protocols. For the first time the indooxine and the Nessler methods are adapted for a plate reader and L-asparaginase serum activity levels are compared by both protocols. Passing-Bablok and Bland-Altman's statistical analyses found very little difference, strong correlation (

Indexed as

acute lymphoblastic leukaemiaindooxineL-asparaginaseL-aspartic acid β-hydroxamate (AHA)Nesslertherapeutic drug monitoring

Identifiers

PMID39539388
PMCPMC11557903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.